{
    "title": "114_hr5845",
    "content": "The \"Budgeting for Opioid Addiction Treatment Act\" establishes an excise tax on opioid pain relievers under section 4192 of the Internal Revenue Code of 1986. The \"Budgeting for Opioid Addiction Treatment Act\" imposes a 1 cent per milligram tax on the sale of taxable active opioids by manufacturers, producers, or importers. Taxable active opioids are defined as controlled substances derived from opium or opiates, excluding prescription medications used solely for opioid addiction treatment. The \"Budgeting for Opioid Addiction Treatment Act\" imposes a 1 cent per milligram tax on taxable active opioids, with subsection (a) applying only to the opioid portion of the product. Clerical amendments are made to the Internal Revenue Code regarding medical products. The table of sections for subchapter E of chapter 32 of the Internal Revenue Code is amended to include a new item. The amendments made by this section regarding opioid pain relievers will apply to sales one year after the enactment of the Act. The Secretary of Health and Human Services will establish a rebate or discount program for eligible cancer and hospice patients paying the tax on opioids. The Secretary will establish a rebate or discount program for eligible cancer and hospice patients to ensure they do not pay any tax on prescribed opioids for pain relief. Eligible patients include those with cancer-related pain or undergoing cancer treatment, as well as patients in hospice care. The Secretary will establish a program for eligible cancer and hospice patients to receive rebates or discounts on prescribed opioids for pain relief. Eligible patients include those with cancer-related pain, undergoing cancer treatment, and patients in hospice care. In cases of death or incapacity, the appropriate family member, medical proxy, or estate of the patient will be involved. SEC. 3. BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE. Amends Public Health Service Act to provide grants to states for substance abuse prevention and treatment programs, including opioid treatment programs. The funding agreement for a grant under section 1921 requires the State to use any increased revenues from the Treasury for substance abuse treatment efforts, including establishing new treatment facilities, sober living facilities, and recruiting mental health providers in underserved communities. The curr_chunk focuses on expanding access to long-term residential treatment programs for opioid addicts, establishing support programs for recovering addicts, housing for children of parents in substance abuse treatment, care for babies with neonatal abstinence syndrome, and other treatment programs as determined appropriate by the Secretary. This is in addition to the funding agreement for grants requiring states to use increased revenues for substance abuse treatment efforts in underserved communities. The curr_chunk discusses amending the Public Health Service Act to include additional funding from increased revenues resulting from the enactment of a specific section of the Internal Revenue Code of 1986. The curr_chunk discusses the requirement for a report to be submitted. The Secretary of Health and Human Services must submit a report to Congress within 2 years on the impact of the amendments on the retail cost of taxable active opioids, patient access to opioids for cancer and hospice patients, the use of increased revenue for substance abuse treatment, and suggestions for improvement. The Secretary of Health and Human Services must submit a report to Congress within 2 years on the impact of amendments on the retail cost of taxable active opioids, patient access to opioids for cancer and hospice patients, and suggestions for improving substance abuse treatment efforts."
}